There are currently 78 active clinical trials seeking participants for Epilepsy research studies. The states with the highest number of trials for Autism participants are Florida, California, Texas and New York.
Intracranial Stimulation Mapping In Epilepsy
Recruiting
This is a single group prospective study to determine the feasibility for generating brain maps that localize cerebral functions and inter-regional information flow in partial epilepsy in adult patients.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/21/2023
Locations: University of Minnesota, Minneapolis, Minnesota
Conditions: Epilepsy
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
Recruiting
This proposal outlines the steps required for the creation of a pilot database of EEG recordings and de-identified medical records from patients internally referred within the UNMH Comprehensive Epilepsy Center. The UNMH EEG Corpus would be the first database of its kind. Other public databases contain either patient EEG signals or medical records, but without both kinds of information, it is impossible to relate pre-treatment neurobiomarkers with post-treatment prognosis. The database will also... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/12/2023
Locations: University of New Mexico Health Science, Albuquerque, New Mexico
Conditions: Epilepsy, Status Epilepticus, Seizures
Neural Circulatory Control and SUDEP Risk.
Recruiting
The investigators believe epilepsy alters the way the body controls blood pressure, heart rate and breathing, and these changes increase the risk of sudden unexpected death in patients with epilepsy (SUDEP). SUDEP-7 is a risk scoring tool which may correlate with these changes to the heart and blood vessels. This research study measures those differences which may help identify new markers to help predict those patients at greatest risk in the future.
Gender:
All
Ages:
Between 18 years and 90 years
Trial Updated:
06/05/2023
Locations: Mayo Clinic, Rochester, Minnesota
Conditions: Epilepsy, Seizures
Sleep Spindles and Memory in Rolandic Epilepsy
Recruiting
The investigators are recruiting children with Rolandic epilepsy and children without epilepsy (aged 4 years old and above) for a non-invasive brain imaging study using Magnetic Resonance Imaging (MRI), Magnetoencephalography/Electroencephalography (MEG/EEG), and experimental tasks. The investigators hope to determine the brain circuits and brain rhythms affected in these children and ultimately identify new treatment options for childhood epilepsy patients.
Gender:
All
Ages:
Between 4 years and 18 years
Trial Updated:
06/01/2023
Locations: Athinoula A. Martinos Center Biomedical Imaging, Charlestown, Massachusetts
Conditions: Rolandic Epilepsy, Rolandic Epilepsy, Benign, Centrotemporal Epilepsy, Centrotemporal; EEG Spikes, Epilepsy of Childhood, Epilepsy; Seizure, Epilepsy
Epidiolex® for Anxiety in Pediatric Epilepsy
Recruiting
This is a prospective open label study assessing the efficacy and tolerability of pharmaceutical grade cannabidiol--Epidiolex (R), for the treatment of anxiety in pediatric patients with pediatric epilepsy that has been difficult to treat and requires ongoing use of anticonvulsant medication.
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
05/15/2023
Locations: Kennedy Krieger Institute, Baltimore, Maryland
Conditions: Anxiety, Epilepsy
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Recruiting
Humans have a remarkable ability to flexibly interact with the environment. A compelling demonstration of this cognitive flexibility is human's ability to respond correctly to novel contextual situations on the first attempt, without prior rehearsal. The investigators refer to this ability as 'ad hoc self-programming': 'ad hoc' because these new behavioral repertoires are cobbled together on the fly, based on immediate demand, and then discarded when no longer necessary; 'self-programming' becau... Read More
Gender:
All
Ages:
Between 10 years and 64 years
Trial Updated:
04/14/2023
Locations: University of California, Los Angeles, Los Angeles, California +2 locations
Conditions: Epilepsy
A Room Temperature Atomic Magnetrode System for Telemetry of Epileptic Seizures
Recruiting
This study is being done to help scientists learn about the use of a device called an atomic magnetometer. The device uses sensors called optically-pumped magnetometers (OPM) which function at room temperature. This research will compare the non-invasive brain imaging application of the OPM sensors to the present SQUID-based cryogenic sensor technique used in conventional Magnetoencephalography (MEG). This study is being conducted in conjunction with the University of Colorado Boulder's Mechani... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
04/13/2023
Locations: University of Colorado School of Medicine - Anschutz Medical Campus, Aurora, Colorado
Conditions: Epilepsy
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome
Recruiting
The goal of this observational study is to learn about the impact of the diabetes drug glibenclamide (glyburide) on neurodevelopment in individuals with iDEND (developmental delay, epilepsy and neonatal diabetes) due to the V59M mutation in the KCNJ11 gene. The main question it aims to answer is whether initiating sulphonylurea (SU) therapy in the first 6 months of life results in better neurodevelopmental outcomes in affected individuals, in comparison to starting therapy later than 6 months of... Read More
Gender:
All
Ages:
Between 2 years and 50 years
Trial Updated:
02/20/2023
Locations: University of Chicago, Chicago, Illinois +3 locations
Conditions: Neurodevelopmental Disorders, Intellectual Disability, Development Delay, ADHD, Autism Spectrum Disorder, Epilepsy
Clinical and Electrographic Changes in Responsive Neurostimulation System (RNS) Patients With Acupuncture Treatment
Recruiting
The purpose of this study is to determine effects of Acupuncture on a Patient's mood and cognition,evaluate changes in clinically-reported seizure frequency and severity and analyze effects of Acupuncture on electrographic epileptiform activity stored by the RNS System
Gender:
All
Ages:
Between 15 years and 60 years
Trial Updated:
02/14/2023
Locations: The University of Texas Health Science Center at Houston, Houston, Texas
Conditions: Epilepsy
EpiCare@Home Validation Study for Focal Onset Seizures
Recruiting
The goal of this clinical trial is to validate a wearable seizure monitoring device, EpiCare@Home, as an objective seizure monitoring tool for people with focal onset epileptic seizures. The device continuously records brain, cardiorespiratory, and physical activity data. The study aims to 1) collect benchmark data for seizure detection algorithm development and validation, and 2) evaluate the performance of the device in clinical and at home workflows. Participants will wear the device during... Read More
Gender:
All
Ages:
12 years and above
Trial Updated:
02/10/2023
Locations: Thomas Jefferson University, Philadelphia, Pennsylvania
Conditions: Epilepsy, Seizures, Seizures, Focal, Seizure, Refractory
Perampanel Titration and Cognitive Effects
Recruiting
The objective of this study is to determine whether there are any differences in the cognitive abilities and/or behavioral response of normal healthy volunteers across different titration rates of perampanel.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
02/04/2023
Locations: Stanford University, Palo Alto, California +2 locations
Conditions: Epilepsy
MR-Guided Focused Ultrasound in the Treatment of Focal Epilepsy (EP001)
Recruiting
The purpose of this study is to evaluate the feasibility, safety, and initial effectiveness of Exablate thermal ablation of a focal epileptic target area in the brain of patients suffering from medication-refractory epilepsy, using the Exablate transcranial system to produce multiple sonications targeted in the focus of interest. The investigators will establish the feasibility and collect data to establish the basic safety of this type of treatment as the basis for later studies that will evalu... Read More
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
09/07/2022
Locations: Stanford University, Stanford, California +3 locations
Conditions: Epilepsy